GlaxoSmithKline Pharmaceuticals has reported results for third quarter ended December 31, 2021.
The company has reported a fall of 4.91% in its net profit at Rs 149.63 crore for the quarter under review as compared to Rs 157.35 crore for the same quarter in the previous year. However, total income of the company marginally increased by 1.43% at Rs 818.48 crore for Q3FY22 as compared Rs 806.96 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 3.94% in its net profit at Rs 150.35 crore for the quarter under review as compared to Rs 156.51 crore for the same quarter in the previous year. However, total income of the company increased by 2.53% at Rs 826.24 crore for Q3FY22 as compared Rs 805.89 crore for the corresponding quarter previous year.
